| $0.242 | -52.90% | 50.92K | ADTX experienced significant losses without specific news, indicating potential negative developments affecting its stock price. |
| $0.203 | -45.70% | 4.46M | YYGH's stock price dropped due to uncertainty from a strategic partnership with Velobotics. |
| $3.100 | -42.16% | 2.04B | Despite $32 million in sponsorships, investor skepticism led to a sharp stock decline. |
| $2.340 | -35.00% | 186.53M | PLYX's stock dropped sharply despite sector strength and overall market gains. |
| $0.189 | -29.99% | 74.26M | GMM experienced severe volatility with a -72.1% drop yesterday amid broader market strength. |
| $8.015 | -29.38% | 210.29M | CRBP's stock fell 10% following disappointing clinical trial results despite a positive response rate. |
| $3.089 | -28.49% | 0.00 | AMSS's stock dropped -19.68% without any recent news to explain the decline. |
| $1.380 | -27.75% | 28.86M | -- |
| $0.115 | -26.81% | 2.09M | -- |
| $0.265 | -25.97% | 21.83M | DBGI experienced a significant price drop of -19.71% without any reported catalysts. |
| $0.498 | -24.66% | 2.64M | Proposed share consolidation of 5:1 to 10:1 raised investor concerns, impacting VMAR's stock price. |
| $2.950 | -23.38% | 19.88M | MTVA surged 34.15% due to advancements in its DA-1726 Phase 1 trial for cardiometabolic diseases. |
| $3.900 | -22.00% | 57.75M | -- |
| $7.250 | -21.54% | 59.12M | QNTM's stock price dropped -18.29% after a significant 47.37% gain, indicating potential overreaction. |
| $1.650 | -21.43% | 12.29M | -- |
| $0.95 | -20.49% | 13.10M | -- |
| $2.120 | -20.00% | 28.04M | -- |
| $1.080 | -19.40% | 2.90M | -- |
| $5.936 | -17.90% | 125.82M | -- |
| $0.228 | -17.84% | 2.27M | Investor sentiment remains cautious despite positive early data for ViraxImmune™ ahead of clinical validation plans. |
| $0.238 | -17.78% | 900.82K | Republic Power Group announced a 1-for-40 reverse stock split, impacting its stock price negatively. |
| $10.130 | -17.37% | 530.18M | -- |
| $0.089 | -16.12% | 2.32M | -- |
| $5.180 | -14.94% | 29.57M | -- |
| $0.896 | -14.66% | 5.93M | -- |
| $0.297 | -14.62% | 36.61M | -- |
| $1.190 | -14.39% | 12.48M | -- |
| $0.9 | -14.28% | 2.90M | -- |
| $1.090 | -14.17% | 10.04M | -- |
| $0.867 | -14.11% | 12.66M | -- |
| $0.768 | -14.01% | 124.90M | -- |
| $0.903 | -13.99% | 2.81M | -- |
| $1.687 | -13.94% | 124.18M | -- |
| $0.321 | -13.80% | 4.71M | -- |
| $0.464 | -13.28% | 36.45M | -- |
| $0.42 | -12.69% | 2.41M | -- |
| $3.000 | -12.66% | 15.34M | -- |
| $0.658 | -12.48% | 3.17M | DXF experienced severe volatility with a -30.96% drop yesterday and -33.99% decline over five days. |
| $0.401 | -12.36% | 42.89M | -- |
| $0.353 | -12.19% | 20.12M | -- |
| $6.095 | -12.05% | 899.85M | -- |
| $0.713 | -11.93% | 179.70M | -- |
| $0.969 | -11.89% | 46.88M | -- |
| $0.43 | -11.78% | 200.27M | -- |
| $0.891 | -11.72% | 57.47M | -- |
| $0.441 | -11.71% | 2.09M | Silexion announced a 1-for-10 reverse stock split, negatively impacting investor sentiment. |
| $1.360 | -11.69% | 26.60M | -- |
| $1.970 | -11.66% | 267.80M | -- |
| $11.450 | -11.65% | 1.56B | -- |
| $1.220 | -11.59% | 5.93M | -- |